Stocks and Investing
Stocks and Investing
Fri, December 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Initiated (ALT) at Strong Buy and Held Target at $20 on, Dec 1st, 2022
Corinne Jenkins of Goldman Sachs, Initiated "Altimmune, Inc." (ALT) at Strong Buy and Held Target at $20 on, Dec 1st, 2022.
Corinne has made no other calls on ALT in the last 4 months.
There are 5 other peers that have a rating on ALT. Out of the 5 peers that are also analyzing ALT, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Corinne
- Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $26 on, Friday, November 11th, 2022
- Seamus Fernandez of "Guggenheim" Maintained at Strong Buy with Decreased Target to $26 on, Friday, September 16th, 2022
- Roger Song of "Jefferies" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 31st, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Wednesday, August 17th, 2022
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $26 on, Friday, August 12th, 2022
Contributing Sources